Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population by Chiang, AKS et al.
Title Associations between IL12B polymorphisms and tuberculosis inthe Hong Kong Chinese population
Author(s) Tso, HW; Yu, LL; Tam, CM; Wong, HS; Chiang, AKS
Citation Journal Of Infectious Diseases, 2004, v. 190 n. 5, p. 913-919
Issued Date 2004
URL http://hdl.handle.net/10722/53448
Rights Journal of Infectious Diseases. Copyright © University ofChicago Press.
IL12B and Tuberculosis • JID 2004:190 (1 September) • 913
M A J O R A R T I C L E
Associations between IL12B Polymorphisms
and Tuberculosis in the Hong Kong Chinese Population
Hoi W. Tso,1 Yu Lung Lau,1 Cheuk M. Tam,2 Hing S. Wong,1 and Alan K. S. Chiang1
1Department of Pediatrics and Adolescent Medicine, the University of Hong Kong, Queen Mary Hospital, and 2Tuberculosis and Chest Service,
Department of Health, Hong Kong Special Administrative Region, China
Background. Interleukin (IL)–12 plays a vital role in regulating cell-mediated immunity against tuberculosis
(TB).
Methods. To test whether IL12B genetic polymorphisms might contribute to human TB susceptibility, we
examined the genotype frequencies of 5 IL12B polymorphisms (at promoter, intron 2, intron 4, exon 5, and 3′
untranslated region [UTR]) in 516 patients with TB and 514 healthy control subjects from the Hong Kong Chinese
population.
Results. Individuals homozygous for the IL12B intron 2–repeat marker (ATT)8 had a 2.1-fold increased risk
of developing TB ( ) (odds ratio, 2.14 [95% confidence interval, 1.45–3.19]). Estimation of the frequenciesP ! .001
of multiple-locus haplotypes composed of IL12B promoter, intron 2, intron 4, and 3′ UTR alleles revealed potential
risk haplotypes (designated “A” and “K”) and protective haplotypes (designated “B”) for TB. Furthermore, com-
bining the genotype data of the 4 informative IL12B loci revealed a strong association between a specific genotype
pattern, termed “diplotype I” (heterozygous A and K haplotypes), and TB. In contrast, diplotype II (homozygous
BB haplotypes) appeared protective against TB.
Conclusions. These findings support the association between IL12B intron 2 polymorphism and TB and
between specific IL12B haplotypes and TB.
One-third of the world’s population is infected with
Mycobacterium tuberculosis. Tuberculosis (TB) has re-
emerged as a leading global health threat, accounting
for 8.7 million new cases and 1.7 million deaths every
year [1]. It is inferred that a role is played by host
genetic factors in TB susceptibility because 10% of in-
fected individuals develop clinical disease [2], there is
higher disease concordance in monozygotic twins than
in dizygotic twins [3, 4], and infection rates differ
among racial groups [5].
The host genetic factors related to TB have been in-
vestigated via 3 different approaches. Linkage studies
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have identified 3 regions, at chromosome 2q35 [6],
15q11-13 [7], and Xq27 [8], that have probable linkages
to TB. Case-control association studies have found sig-
nificant associations between gene polymorphisms in
NRAMP1 [9], HLA [10], vitamin D receptor [11], man-
nose-binding lectin [12], interleukin (IL)–1 [13], IL-1b,
IL-1 receptor antagonist [14], surfactant proteins [15],
P2X7 [16], interferon (IFN)–g [17], IL-10 [18], IL-12
receptor [19], and IL-8 [20] and TB. Mendelian suscep-
tibility to mycobacterial infections, which is caused by a
mutation in a single major gene, indicates that a critical
role is played by the IL-12–IFN-g cytokine axis in host
immunity against the disease [21]. In knockout murine
models, IL-12–deficient mice are more susceptible to in-
fection with M. bovis bacille Calmette-Gue´rin [22] and
M. tuberculosis [23] than are wild-type mice. In addition,
IL12B-deficient mice develop more severe mycobacterial
infection than do IL12A-deficient mice [24].
IL-12 is a heterodimeric cytokine that is composed
of 2 subunits, p35 and p40, and that plays an essential
role in the induction and maintenance of Th1 responses
[25]. Polymorphisms in IL12B have been reported at
promoter [26], intron 2 [27], intron 4 [28], exon 5
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Table 1. Primers, probes, and genotyping methods for IL12B polymorphisms.
Sequence
(5′r3′)
Polymorphic sitea Forward Reverse Genotyping methodb
Promoterc [26] GGTCATTGGCAGGTTGTTCT CGCCCATAGGGTAAGCAATA The polymorphism was a 7-bp deletion and 3-bp insertion, leading to an
allelic difference of 4 bp. The shorter allele (1) and the longer allele (2)
were genotyped by use of the ABI PRISM 700 Sequence Detection
System (Applied Biosystems), with TaqMan probes (Applied
Biosystems).
Intron 2 [27] FAM-GACTGAGGAGTCAGCCAACTG TTGGCCTCAGTACGCTTCTT Allele 1 (ATT)8 and allele 2 (ATT)9 were amplified with fluorescence-labeled
forward primers and were analyzed by use of ABI PRISM 377 DNA Se-
quencers and GeneScan software (version 3.1) (Applied Biosystems).
Intron 4 [28] FAM-GTCATGGAGAGCTCCCCATA TGGCCAGAACTTTTCAATG Allele 1 (TA)10(TG)10 and allele 2 (TA)9(TG)9 were genotyped by the same
method as that described for intron 2.
Exon 5 [29] GAGGAGAGTCTGCCCATTGA GATCTGGGGCAAGTTGCTTA Allele serine (AGC) and allele asparagine (AAC) were distinguished by over-
night digestion at 37C with Fnu4HI (New England Biolab), because al-
lele serine gained a Fnu4HI site.
3′ UTR [28, 30] TGATCCAGGATGAAAATTTGG GGCAACTTGAGAGCTGGAAA Allele 1 (A) and allele 2 (C) were genotyped by overnight digestion at 65C
with TaqI (Invitrogen), because allele 2 created a TaqI restriction site.
NOTE. UTR, untranslated region.
a The original reference paper(s) describing each IL12B polymorphism is provided.
b The 2 alleles at each polymorphic locus are designated “1” and “2.”
c TaqMan probes used for the promoter allele were FAM-CCACATTAGAGCCTCTC and VIC-CCACAGCCCTCTCT.
[29], and 3′ untranslated region (UTR) [28, 30]. The allelic
variants at 3′ UTR and promoter have different effects on IL12B
mRNA [31] and IL-12p70 protein expression levels [26, 32].
Because IL-12 is a key Th1 cytokine that protects individ-
uals from mycobacterial infection, we hypothesized that genetic
polymorphisms in IL12B might contribute to TB susceptibility
in the general population. To test this hypothesis, we first in-
vestigated whether any associations between 5 reported IL12B
polymorphisms and TB could be found in 516 patients with
TB and 514 healthy control subjects. Second, we performed
functional analysis to correlate the associated polymorphisms
with IL-12p70 protein expression.
PATIENTS, MATERIALS, AND METHODS
Study populations. The present study was approved by the
ethics committees of the Faculty of Medicine, the University
of Hong Kong, and of the Department of Health, Hong Kong
Special Administrative Region (HKSAR), China. The study par-
ticipants included 516 Hong Kong Chinese patients with TB
(mean age, 48 years [SD, 18.0 years]; number of men, 328;
number of women, 188), who provided informed consent and
were recruited over a 2-year period (2000–2002) from territory-
wide chest clinics that operate under the Department of Health
of the HKSAR. All patients had established TB. Sixty percent
were either culture or smear positive for M. tuberculosis. The
remaining patients satisfied the TB diagnostic criteria of the
International Union against Tuberculosis and Lung Diseases
[33] and were diagnosed on the basis of clinical-radiological
and histological grounds and of positive response to antimy-
cobacterial treatment. None of the patients was infected with
HIV. The control subjects included 514 healthy, unrelated, and
ethnically matched Hong Kong Chinese blood donors from the
Hong Kong Red Cross, who were recruited during 2001–2003
(mean age, 28 years [SD, 10.4 years]; number of men, 356;
number of women, 158).
DNA extraction. Genomic DNA was isolated from whole
blood that had been collected from patients with TB and from
buffy-coat lymphocytes from control subjects, according to a stan-
dard procedure [34] or by use of a DNA extraction kit (Qiagen).
IL12B genotyping. The sequences of all primers and probes
and the genotyping methods for 5 IL12B polymorphisms (at
promoter, intron 2, intron 4, exon 5, and 3′ UTR) are described
in table 1. Each polymorphic locus consists of 2 alleles (designat-
ed “1” and “2”) except for intron 4, where other minor alleles
are also present (table 1). Polymerase chain reaction (PCR) was
performed in a 50-mL reaction mixture containing 50 ng geno-
mic DNA, 0.2 mmol/L primers, 1.5 mmol/L MgCl2, 0.2 mmol/L
dNTPs, and 0.5 U Taq DNA polymerase (Amersham). The PCR
mixture was incubated initially for 2 min at 95C and was fol-
lowed by 35 cycles of denaturation for 1 min at 95C, annealing
for 1 min at 60C, and extension for 1 min at 72C; final exten-
sion was for 5 min at 72C.
Genotype analyses. The genotype frequencies of each of the
IL12B polymorphisms were determined in the 516 patients with
TB and the 514 control subjects (table 2). Because the allele
frequency of asparagine (AAC) in exon 5 was !1%, this allele
was considered an uncommon variant in the Hong Kong Chi-
nese population, and exon 5 was excluded from further anal-
yses. At each polymorphic locus, the genotype frequencies of
the patients with TB and the control subjects were compared,
and odds ratios (OR) were calculated by assigning the reference
value (1.0) to the homozygous genotype that was more frequent
in the control subjects than in the patients with TB. The OR
and P values were calculated by multiple logistic regression
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Table 2. IL12B genotype frequencies in patients with tuber-
culosis (TB) and in control subjects.
IL12B
genotype
Patients
with TB
(n p 516)
Control
subjects
(n p 514)
Multiple logistic
regressiona
OR (95% CI) P
Promoter .038
1/1 147 (28) 134 (26) 1.46 (0.99–2.15) …
1/2 251 (49) 225 (44) 1.53 (1.08–2.16) …
2/2 118 (23) 155 (30) Reference …
Intron 2 !.001
1/1 203 (39) 149 (29) 2.14 (1.45–3.19) …
1/2 224 (43) 239 (46) 1.40 (0.96–2.04) …
2/2 89 (17) 126 (25) Reference …
Intron 4 .014
1/1 147 (28) 139 (27) 1.64 (1.09–2.50) …
1/2 238 (46) 220 (43) 1.05 (0.76–1.49) …
2/2 81 (16) 121 (24) Reference …
Othersb 50 (10) 34 (7) 0.68 (0.39–1.19) …
3′ UTR .027
1/1 166 (32) 143 (28) 1.79 (1.16–2.77) …
1/2 280 (54) 273 (53) 1.56 (1.03–2.30) …
2/2 70 (14) 98 (19) Reference …
NOTE. Data are no. (%) of patients with TB or control subjects, unless
otherwise noted. CI, confidence interval; OR, odds ratio; UTR, untranslated
region.
a Genotype frequencies at each polymorphic locus were compared be-
tween the patients with TB and the control subjects, and ORs were calculat-
ed by assigning the reference value (1.0) to the homozygous genotype that
was more frequent in the control subjects than in the patients with TB. The
OR and P values were calculated by multiple logistic regression analysis, ad-
justed for the age and sex of the patients with TB and the control subjects.
was considered to be significant.P ! .05
b Repeats other than (TA)10(TG)10 and (TA)9(TG)9 were grouped together.
analysis, adjusted for the age and sex of the patients with TB
and the control subjects. A P value !.05 was considered to be
significant. In addition, we analyzed, for genotype frequency,
the 306 culture- or smear-positive patients with TB from the
entire cohort of 516 patients and compared them with the 514
control subjects. The genotype distributions of all 4 informative
polymorphisms (at promoter, intron 2, intron 4, and 3′ UTR)
were tested for Hardy-Weinberg equilibrium (HWE) separately
in the patients with TB and the control subjects, by x2 test.
Statistical analyses were conducted by use of SAS software (ver-
sion 8.2; SAS Institute).
Haplotype analyses. The frequencies of multiple-locus
haplotypes composed of the IL12B promoter, intron 2, intron
4, and 3′ UTR alleles were estimated by performing the hap-
lotype procedure of the SAS/Genetics software (version 8.2; SAS
Institute), which uses the expectation-maximization (EM) al-
gorithm to generate maximum-likelihood estimates of haplo-
type frequencies given multiple genetic-marker genotypes un-
der the assumption of HWE [35] (table 3). To test the overall
difference in haplotype frequency between the patients with TB
and the control subjects, the haplotype procedure was per-
formed for the patients, for the control subjects, and for the
patients and control subjects combined. The relevant test sta-
tistic was defined as , where lnGp2(ln L  ln L  ln L )PC P C
LPC is the natural logarithm of the maximum-likelihood esti-
mates for patients plus control subjects, ln LP is the natural
logarithm of the maximum-likelihood estimates for the patients
with TB, and ln LC is the natural logarithm of the maximum-
likelihood estimates for the control subjects. With large sample
sizes, the distribution of G approximates a x2 distribution, with
df equal to the number of haplotypes estimated [35].
Diplotype analyses. We combined the genotype data of
the 4 IL12B polymorphic loci for each of the 516 patients with
TB and the 514 control subjects. The frequencies of the multi-
ple-locus genotypes (termed “diplotypes”) in the patients and
control subjects are cross-tabulated in table 4. The overall dif-
ference in diplotype frequency between patients with TB and
control subjects was evaluated by x2 test.
IL-12p70 assay. Peripheral-blood mononuclear cells (PBMCs)
from 98 randomly selected control subjects were obtained, and
the IL12B genotypes of each subject were determined. PBMCs
were cultured at a concentration of cells/mL in 24-well,61 10
round-bottomed tissue-culture plates (Corning Costar), in 1
mL of RPMI 1640 medium (Gibco) with 10% fetal bovine
serum (Gibco). The cells were stimulated with 100 ng/mL IFN-
g (R&D Systems) for 2 h at 37C, followed by the addition of
10 ng/mL lipopolysaccharide (Sigma). Culture supernatants
were harvested at 16 h, and IL-12p70 concentration was assayed
in duplicate by ELISA, according to the manufacturer’s instruc-
tions (DuoSet ELISA Development Kit; R&D Systems). Cor-
relation of IL-12p70 protein levels and genetic polymorphisms
was analyzed by the Mann-Whitney U test.
RESULTS
Association between 1/1 genotype of IL12B intron 2 and TB.
Significant differences between the genotype frequencies of pro-
moter, intron 2, intron 4, and 3′ UTR polymorphisms of IL12B
in patients with TB and those in control subjects were detected
( ) (table 2). Intron 2 polymorphism showed the mostP ! .05
significant result. Individuals homozygous for the 1/1 genotype
of intron 2 had a 2.14-fold increased risk of developing TB
(95% confidence interval [CI], 1.45–3.19 [ ]). Impor-P ! .001
tantly, the genotype analyses of the whole cohort of 516 patients
with TB and of the subset of 306 culture- or smear-positive
patients with TB yielded very similar genotype frequencies,
ORs, and P values for all 4 informative IL12B polymorphisms
(see the Appendix). In the latter analysis, the OR for the 1/1
genotype of intron 2 was 1.98, with a 95% CI of 1.25–3.13 and
P value of .009. Therefore, we used the whole cohort of 516
patients with TB for subsequent analysis. The genotype fre-
quencies of all 4 informative IL12B polymorphisms in the pa-
tients with TB and in the control subjects were in HWE, except
for (1) excess homozygosity at promoter genotypes in the con-
trol subjects and (2) excess homozygosity and excess hetero-
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Table 3. Estimated IL12B haplotype frequencies in patients with tuberculosis (TB) and
in control subjects.
IL12B
haplotypea Promoter Intron 2 Intron 4 3′ UTR
Percentage (95% CI)
Patients with
TB
(n p 516)
Control
subjects
(n p 514)
A 1 1 1 1 42.2 (39.2–45.3) 35.4 (32.5–38.4)
B 2 2 2 2 26.9 (24.2–29.6) 34.8 (31.9–37.7)
C 2 1 1 1 6.6 (5.1–8.2) 7.0 (5.5–8.6)
D 2 2 2 1 3.0 (1.9–4.0) 3.7 (2.5–4.8)
E 1 2 2 2 3.7 (2.6–4.9) 3.3 (2.2–4.4)
F 1 1 1 2 1.3 (0.6–2.0) 2.6 (1.7–3.6)
G 1 1 2 1 0.6 (0.1–1.1) 2.5 (1.5–3.4)
H 2 2 1 2 0.7 (0.2–1.1) 2.1 (1.2–3.0)
I 1 2 1 1 1.2 (0.5–1.9) 1.1 (0.5–1.7)
J 2 2 1 1 1.3 (0.6–2.0) 1.1 (0.5–1.7)
K 2 1 2 2 4.5 (3.3–5.8) 0.6 (0.1–1.1)
L 2 1 1 2 1.1 (0.5–1.8) 0.7 (0.2–1.2)
NOTE. The frequencies of multiple-locus haplotypes composed of IL12B promoter, intron 2, intron 4,
and 3′ UTR alleles were estimated by use of the expectation-maximization algorithm. Frequencies are given
in percentages. An overall difference in haplotype frequency between the patients with TB and the control
subjects was found ( ). The test statistic was defined as , where ln LPC isP ! .001 Gp2(lnL  lnL  lnL )PC P C
the natural logarithm of the maximum-likelihood estimates for patients plus control subjects, ln LP is the
natural logarithm of the maximum-likelihood estimates for the patients with TB, and ln LC is the natural
logarithm of the maximum-likelihood estimates for the control subjects. CI, confidence interval; UTR, un-
translated region.
a Twelve haplotypes (designated “A–L”) with frequencies 11% are shown.
zygosity at intron 2 and 3′ UTR genotypes, respectively, in the
patients with TB. Our sample of patients with TB consisted
mainly of individuals who were newly diagnosed at territory-
wide chest clinics, which treat 190% of newly diagnosed pa-
tients with TB in Hong Kong. Furthermore, the cohort of 516
patients with TB had characteristics (male, 69.1%; mean age,
48.4 years [SD, 19.8 years]; pulmonary TB, 86.3%) that were
similar to those in a large survey of 5757 patients with TB who
registered for treatment in Hong Kong during 1996 [36]. De-
parture from HWE in the patients with TB probably represented
the association between TB and the intron 2 allele and a particular
haplotype in our population, rather than sampling bias.
Associations between risk haplotypes (designated “A” and
“K”) of IL12B and TB and between a protective haplotype
(designated “B”) of IL12B and TB. Estimation of the hap-
lotype frequencies from the diploid genotype data was per-
formed by use of the EM algorithm [35]. In the total sample
of patients with TB and control subjects, 12 of the 38 possible
haplotypes composed of the promoter, intron 2, intron 4, and
3′ UTR alleles of IL12B had frequencies 11% (table 3). Most
of the remaining haplotypes had frequencies of zero or of close
to zero. We tested the genotype frequencies for HWE separately
in the patients with TB and the control subjects and noted
deviations from HWE in 1 locus in the control subjects and
in 2 loci in the patients with TB, as described above. Estimation
error might result from these HWE deviations. However, the
HWE deviations in our sample were mainly due to excess ho-
mozygosity (2 of 3 loci), which caused little increase in error
between the EM estimates and the sample values [37]. Hap-
lotypes A and B account for ∼70% of the total haplotypes of
IL12B in the Hong Kong Chinese population. An overall dif-
ference in haplotype frequency between the patients with TB
and the control subjects was found ( ). Among the dif-P ! .001
ferent IL12B haplotypes, haplotypes A and K occurred at higher
frequencies in the patients with TB than in the control subjects,
whereas the converse was found for haplotype B, with no over-
lapping of the 95% CIs for the haplotype frequencies in the
patients with TB and the control subjects (table 3).
Associations between a risk diplotype (designated “I”) of
IL12B and TB and between a protective diplotype (designated
“II”) of IL12B and TB. We combined the genotypes at each
of the 4 informative IL12B polymorphic loci (promoter, intron
2, intron 4, and 3′ UTR) and observed 61 diplotypes in the
patients with TB and the control subjects. In the total sample
of patients and control subjects, one-quarter of the diplotypes
had frequencies 11%. The remaining diplotypes were grouped
together as “others” (table 4). An overall difference in diplotype
frequency between patients with TB and control subjects was
found ( ). Furthermore, diplotype I (composed of A andP ! .001
K haplotypes) was found to be strongly associated with TB, with
25 patients with TB and none of the control subjects showing
the genotype pattern. In contrast, diplotype II (homozygous BB
haplotypes) was underrepresented in patients with TB, compared
with its frequency in control subjects (table 4).
IL-12p70 expression levels and IL12B genetic polymor-
phisms. To investigate whether IL12B genetic polymorphisms
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Table 4. IL12B diplotype frequencies in patients with tuberculosis (TB) and in control subjects.
IL12B
diplotypea Promoter Intron 2 Intron 4 3′ UTR
No. (%)
Possible haplotype
combinations
Patients with TB
(n p 516)
Control subjects
(n p 514)
I 1/2 1/1 1/2 1/2 25 (4.8) 0 (0) AK 11 GL
II 2/2 2/2 2/2 2/2 32 (6.4) 60 (11.7) BB only
III 1/2 1/2 2/2 1/2 0 (0) 10 (1.9) BG only
IV 1/1 1/1 1/1 1/1 89 (17.2) 79 (15.4) AA only
V 1/2 1/2 1/2 1/2 136 (26.4) 132 (25.7) AB, CE, DF, GH, IK
VI 1/1 1/1 1/1 1/2 8 (1.5) 8 (1.6) AF only
VII 1/1 1/2 1/2 1/2 17 (3.3) 12 (2.3) AE only
VIII 1/2 1/1 1/1 1/2 7 (1.4) 3 (0.6) AL, CF
IX 1/2 1/2 1/2 1/1 7 (1.4) 7 (1.4) AD, GJ
X 1/2 2/2 2/2 2/2 9 (1.7) 12 (2.3) BE only
XI 2/2 1/1 1/1 1/1 4 (0.8) 7 (1.4) CC only
XII 2/2 1/2 1/2 1/2 22 (4.3) 35 (6.8) BC, DL, JK
XIII 2/2 2/2 2/2 1/2 15 (2.9) 19 (3.7) BD only
Others … … … … 144 (27.9) 130 (25.3) …
NOTE. The frequencies of the multiple-locus genotypes (termed “diplotypes”) in patients with TB and control subjects are cross-
tabulated here. An overall difference in diplotype frequency between the patients with TB and the control subjects was found (P !
, x2 test). UTR, untranslated region..001
a Thirteen diplotypes (designated “I”–”XIII”) with frequencies 11% are shown.
are associated with gene expression, we stimulated PBMCs from
98 randomly selected control subjects for IL-12p70 production.
A stronger trend for IL-12p70 production was observed in hap-
lotype B carriers ( ; median, 352 pg/mL), compared withnp 57
non–haplotype B carriers ( ; median, 283 pg/mL) (Ppnp 41
.154), whereas a weaker trend for IL-12p70 production was
observed in IL12B promoter heterozygotes ( ; median,np 45
287 pg/mL), compared with IL12B promoter homozygotes
( , median, 357 pg/mL) ( ). Large variations innp 53 Pp .423
levels of IL-12p70 expression among individuals with the same
IL12B genotypes were observed, and no statistical correlation
between levels of IL-12p70 expression and specific IL12B ge-
netic polymorphisms was found.
DISCUSSION
To test whether there is an association between IL12B polymor-
phisms and TB susceptibility, we performed a large-scale pop-
ulation-based case-control study involving 11000 individuals
from the Hong Kong Chinese population. Whether the whole
cohort of 516 patients with TB or just the 306 culture- or smear-
positive patients were considered, the genotype analyses showed
that individuals homozygous for the intron 2 (ATT)8 allele of
IL12B had a 2-fold increased risk for TB. Only one study has
reported an association between intron 2 polymorphism of IL12B
and clinical disease; in white American families, the intron 2
(ATT)9 allele has been found to be preferentially transmitted to
individuals with type 1 diabetes [27]. Our findings for patients
with TB could reconcile with those for individuals with type 1
diabetes, because we found the intron 2 (ATT)9 allele to be pro-
tective against an infectious disease such as TB, whereas the same
allele appeared to be a risk factor for an autoimmune disease
such as diabetes. This finding is consistent with the observation
that IL-12 is a costimulator of protective immune responses as
well as a mediator of immunopathological diseases.
We next estimated the frequencies of IL12B haplotypes com-
posed of 4 informative polymorphic alleles at promoter, intron
2, intron 4, and 3′ UTR and identified risk (A and K) and pro-
tective (B) haplotypes. In agreement with the genotype findings,
the intron 2 (ATT)8 allele was contained in the risk haplotypes
A and K, whereas the alternative (ATT)9 allele was contained in
the protective haplotype B. Correlation of the haplotypes and
the diplotypes revealed interesting results. Diplotype I (hetero-
zygous A and K haplotypes) was found in only 25 patients with
TB and in none of the control subjects. The other probable
pairings of haplotypes for diplotype I were unlikely, because they
involved haplotypes with low frequencies and at least 1 haplotype
with a frequency !1% (tables 3 and 4). Because diplotype IV
(homozygous AA haplotypes) occurred at similar frequencies in
patients with TB and control subjects, it was inferred that hap-
lotype K might be strongly linked to a TB-susceptibility locus.
In contrast to haplotypes A and K, haplotype B was found
to confer resistance to TB. Both diplotypes II (homozygous BB
haplotypes) and III (heterozygous B and G haplotypes) oc-
curred at higher frequencies in control subjects, compared with
those in patients with TB. Diplotype II was found in twice the
number of control subjects than in patients with TB, and dip-
lotype III was found in 10 of the control subjects and in none
of the patients with TB. The effect that haplotype G has on
resistance to TB is probably small, because it was found to be
rare in both the patients with TB and the control subjects. A
particular IL12B haplotype (allele 2 at the promoter and allele
2 at 3′ UTR) was found to be associated with fatal cerebral
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malaria in Tanzanians [38]. In our study population, 9% of
patients with TB and 14% of control subjects were homozygous
for this haplotype, which indicates that it plays a protective
role against TB (OR, 0.60 [95% CI, 0.41–0.88]) ( ).Pp .012
The discordant effects that the IL12B haplotype has on malaria
and TB might reflect the complexity of the influence of IL-12
and its genetic polymorphisms on host immune responses
against different infectious diseases.
We attempted to correlate the IL12B haplotypes and levels
of IL-12p70 expression. A higher median level of IL-12p70 was
observed in haplotype B carriers, compared with non–haplo-
type B carriers; however, the result did not reach statistical
significance. We could not investigate the level of IL-12p70
expression in individuals with diplotype I, because of the low
frequency of such individuals among the control subjects. To
date, no functional studies have reported on IL12B intron 2
and 4 polymorphisms; conflicting results have been reported
on the functional effects of 3′ UTR polymorphisms. Morahan
et al. [31] indicated that IL12B mRNA expression was signif-
icantly reduced in Epstein-Barr virus–transformed cell lines of
the 3′ UTR 2/2 genotype, compared with those of the 3′ UTR
1/1 genotype. Dahlman et al. [39] examined 19 cell lines of 3
different 3′ UTR genotypes but did not find any correlation
between genotype and expression; wide variation in levels of
expression between different B-lymphoblastoid cell lines, in-
dependent of 3′ UTR genotype, was observed. Contrary to the
findings of Morahan et al., Seegers et al. [32] demonstrated an
association between significantly higher IL-12p70 protein levels
and the 3′ UTR 2/2 genotype, after stimulation of monocytes
with Staphylococcus aureus strain Cowan and IFN-g. Such in-
consistent results might be due in part to different experiment
protocols, but they could also be due to factors other than
IL12B genotypes regulating the expression of IL-12. We also
found great variation in levels of IL-12p70 expression among
individuals with the same IL12B genotypes. Furthermore, after
multiple logistic regression, we did not observe any strong in-
dependent effect of 3′ UTR polymorphism on TB susceptibility,
which concurs with the observed lack of association between
3′ UTR polymorphism of IL12B and TB susceptibility in a case-
control study of African American and white populations [40].
However, the latter study did not evaluate the effects of other
IL12B polymorphisms.
Morahan et al. [26] found reduced IL12B gene transcription
and decreased secretion of IL-12p70 in asthmatic children with
IL12B promoter heterozygosity. We found a weaker trend for
levels of IL-12p70 expression in IL12B promoter heterozygotes
than in homozygotes among the control subjects in our pop-
ulation, but there was substantial overlap of levels between the
2 groups, as well as great variation in the levels of IL-12 among
individuals. Taken together, the current functional assays of
levels of IL-12 expression are confounded by the large natural
variation in cytokine production among different individuals.
A better standardized biologic assay system is needed to dissect
genotype-phenotype correlation.
In summary, the present study supports the association be-
tween IL12B intron 2 polymorphism and TB and between spe-
cific haplotypes and TB. Novel risk and protective haplotypes
of IL12B have been identified, of which haplotype K was found
to be strongly linked to TB susceptibility and haplotype B was
found to confer a protective effect. Further genetic and biologic
studies of these haplotypes should render valuable insight into
TB susceptibility.
APPENDIX
IL12B genotype frequencies in culture- or smear-positive pa-
tients with tuberculosis (TB) and in control subjects.
IL12B
genotype
Patients
with TB
(n p 306)
Control
subjects
(n p 514)
Multiple logistic
regressiona
OR (95% CI) P
Promoter .126
1/1 92 (30) 134 (26) 1.40 (0.90–2.19) …
1/2 144 (47) 225 (44) 1.50 (1.00–2.25) …
2/2 70 (23) 155 (30) Reference …
Intron 2 .009
1/1 124 (41) 149 (29) 1.98 (1.25–3.13) …
1/2 129 (42) 239 (46) 1.34 (0.86–2.09) …
2/2 53 (17) 126 (25) Reference …
Intron 4 .014
1/1 87 (28) 139 (27) 1.59 (0.97–2.56) …
1/2 136 (44) 220 (43) 1.08 (0.72–1.61) …
2/2 49 (16) 121 (24) Reference …
Othersb 34 (11) 34 (7) 0.53 (0.28–0.99) …
3′ UTR .100
1/1 104 (34) 143 (28) 1.70 (1.03–2.80) …
1/2 158 (52) 273 (53) 1.52 (0.95–2.42) …
2/2 44 (14) 98 (19) Reference …
NOTE. Data are no. (%) of patients with TB or control subjects,
unless otherwise noted. CI, confidence interval; OR, odds ratio; UTR,
untranslated region.
a Genotype frequencies at each polymorphic locus were com-
pared between the patients with TB and the control subjects, and
ORs were calculated by assigning the reference value (1.0) to the
homozygous genotype that was more frequent in the control sub-
jects than in the patients with TB. The OR and P values were cal-
culated by multiple logistic regression analysis, adjusted for the age
and sex of the patients with TB and the control subjects. wasP ! .05
considered to be significant.
b Repeats other than (TA)10(TG)10 and (TA)9(TG)9 were grouped
together.
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